孕前糖尿病患者的妊娠期高血压疾病在阿司匹林指南发布前后的变化
该研究基于2010至2018年美国国家生命统计系统数据,对224,065例孕前糖尿病且至少一次单胎>20周分娩者进行重复横断面分析,比较美国预防服务工作组指南发布前(2010-2013)与发布后(2015-2018)队列。指南发布后分娩与妊娠期高血压疾病(调整OR 1.25,95%CI 1.22-1.28)和早产(调整OR 1.10,95%CI 1.08-1.12)风险升高相关,在产前保健可及性不足者中更明显。
要点
- 美国预防服务工作组2014年指南推荐高危患者孕12至28周开始低剂量阿司匹林预防子痫前期。
- 孕前糖尿病者指南发布后分娩与妊娠期高血压疾病风险升高相关(调整OR 1.25,95%CI 1.22-1.28)。
- 孕前糖尿病者指南发布后分娩与早产风险升高相关(调整OR 1.10,95%CI 1.08-1.12)。
核心结论
- 在美国预防服务工作组阿司匹林指南发布后分娩,与糖尿病患者人群中更高的妊娠期高血压疾病和早产率相关。
- 尚不清楚患者或从业者因素或其他产科护理变化是否促成了这些发现。
研究设计与样本
- 重复横断面分析,纳入2010至2018年美国国家生命统计系统中孕前糖尿病且至少1次单胎>20周分娩并有记录者。
- 比较美国预防服务工作组指南发布前队列(2010-2013)与发布后队列(2015-2018)的人口学和临床特征。
- 采用多变量回归估计指南发布与所选终点之间关联的比值比和95%置信区间。
- 使用Kotelchuck指数(<80% vs ≥80%)评估产前保健可及性的效应修饰。
- 进行仅限于初产妇的敏感性分析。
主要发现
- 共纳入224,065例个体。
- 指南发布后队列更可能年龄较大、肥胖和有早产史。
- 在未调整和调整模型中,指南发布后队列分娩与妊娠期高血压疾病相关(调整OR 1.25,95%CI 1.22-1.28)。
- 在未调整和调整模型中,指南发布后队列分娩与早产相关(调整OR 1.10,95%CI 1.08-1.12)。
- 在产前保健可及性低于充足者中,妊娠期高血压疾病和早产的调整OR更为明显;仅初产妇的敏感性分析结果相似。
关键数值与推荐
- 美国预防服务工作组2014年指南推荐高危患者孕12至28周开始低剂量阿司匹林以预防子痫前期。
- 一些临床医生推荐低剂量阿司匹林用于预防早产。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The US Preventive Services Taskforce published guidelines in 2014 recommending that low-dose aspirin be initiated between 12 and 28 weeks of gestation among high-risk patients for preeclampsia prophylaxis. Moreover, low-dose aspirin is recommended by some clinicians for the prevention of preterm birth. OBJECTIVE: This study aimed to evaluate whether there is an association between the US Preventive Services Taskforce aspirin guideline hypertensive disorders of pregnancy and the rates of hypertensive disorders of pregnancy and preterm birth in individuals with pregestational diabetes mellitus. STUDY DESIGN: This was a repeated cross-sectional analysis of individuals with pregestational diabetes mellitus and at least 1 singleton delivery at >20 weeks of gestation with records available in the National Vital Statistics System between 2010 and 2018. The primary outcome was hypertensive disorders of pregnancy, and the secondary outcome was preterm birth. Demographics and clinical characteristics among individuals in the pre-US Preventive Services Taskforce guideline cohort (2010-2013) were compared with that of individuals in the post-US Preventive Services Taskforce guideline cohort (2015-2018). Multivariable regression estimated the odds ratios and 95% confidence intervals for the association between guideline publication and the selected endpoints. Effect modification was assessed for access to prenatal care using the Kotelchuck Index (<80% vs ≥80%). Furthermore, a sensitivity analysis limited to nulliparas was performed. RESULTS: Overall, 224,065 individuals were included. Individuals in the post-US Preventive Services Taskforce guideline cohort were more likely to be older, be obese, and have a history of preterm birth. In unadjusted and adjusted modeling, delivery in the post-US Preventive Services Taskforce guideline cohort was associated with hypertensive disorders of pregnancy (adjusted odds ratio, 1.25; 95% confidence interval, 1.22-1.28) and preterm birth (adjusted odds ratio, 1.10; 95% confidence interval, 1.08-1.12). The adjusted odds ratios for hypertensive disorders of pregnancy and preterm birth were more pronounced among those with less than adequate access to care. The findings were similar in the sensitivity analysis of only nulliparas. CONCLUSION: Delivery after US Preventive Services Taskforce aspirin guideline publication was associated with higher rates of hypertensive disorders of pregnancy and preterm birth in a population of individuals with diabetes mellitus. It is unknown whether patient or practitioner factors, or other changes in obstetrical care, contributed to these findings.
引用
- Bruno AM, Allshouse AA, Metz TD, et al. Hypertensive disorders of pregnancy pre- and postaspirin guideline publication in individuals with pregestational diabetes mellitus. Am J Obstet Gynecol MFM. 2023. PMID: 36708967. doi:10.1016/j.ajogmf.2023.100877
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。